Global RNAi Technologies Market Analysis & Trends - Industry Forecast to 2027

  • ID: 4699564
  • Report
  • Region: Global
  • 158 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Alnylam Pharmaceuticals
  • Benitec Biopharma Ltd
  • F. Hoffmann-La Roche Ag
  • General Electric Co.
  • Ionis Pharmaceuticals
  • Nitto Denko Corp.
  • MORE
The Global RNAi Technologies Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include rise in number of genetic and metabolic disorders, improvement in synthetic delivery carriers and chemical modifications to RNA, recent technological developments in RNAi technologies and growth opportunities/investment opportunities.

Based on therapeutics, market is segmented into ocular disorders, respiratory disorders, cardiology, neurology, liver diseases, oncology, metabolic disorders, ophthalmology, heart ailment and autoimmune hepatitis.

By application, market is classified into drug discovery, medical research and agriculture. Medical research is further divided into functional genomics and specifically metabolism. On basis of type, market is divided into micro RNAi and small interfering RNAi.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:
North America
  • US
  • Canada
  • Mexico
Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
Middle East
  • Saudi Arabia
  • UAE
  • Rest of Middle East
Latin America
  • Argentina
  • Brazil
  • Rest of Latin America
Rest of the World
  • South Africa
  • Others
Report Highlights:
  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alnylam Pharmaceuticals
  • Benitec Biopharma Ltd
  • F. Hoffmann-La Roche Ag
  • General Electric Co.
  • Ionis Pharmaceuticals
  • Nitto Denko Corp.
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Application Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Rise in Number of Genetic and Metabolic Disorders
3.1.2 Improvement in Synthetic Delivery Carriers and Chemical Modifications to RNA
3.1.3 Recent Technological Developments in RNAi Technologies
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 RNAi Technologies Market, By Therapeutics
4.1 Ocular disorders
DATA TABLE Ocular disorders Market Forecast to 2027 (US$ MN)
4.2 Respiratory disorders
DATA TABLE Respiratory disorders Market Forecast to 2027 (US$ MN)
4.3 Cardiology
DATA TABLE Cardiology Market Forecast to 2027 (US$ MN)
4.4 Neurology
DATA TABLE Neurology Market Forecast to 2027 (US$ MN)
4.5 Liver diseases
DATA TABLE Liver diseases Market Forecast to 2027 (US$ MN)
4.6 Oncology
DATA TABLE Oncology Market Forecast to 2027 (US$ MN)
4.7 Metabolic disorders
DATA TABLE Metabolic disorders Market Forecast to 2027 (US$ MN)
4.8 Ophthalmology
DATA TABLE Ophthalmology Market Forecast to 2027 (US$ MN)
4.9 Heart ailment
DATA TABLE Heart ailment Market Forecast to 2027 (US$ MN)
4.10 Autoimmune hepatitis
DATA TABLE Autoimmune hepatitis Market Forecast to 2027 (US$ MN)

5 RNAi Technologies Market, By Application
5.1 Drug discovery
DATA TABLE Drug discovery Market Forecast to 2027 (US$ MN)
5.2 Medical research
DATA TABLE Medical research Market Forecast to 2027 (US$ MN)
5.2.1 Functional genomics
DATA TABLE Functional genomics Market Forecast to 2027 (US$ MN)
5.2.2 Specifically metabolism
DATA TABLE Specifically metabolism Market Forecast to 2027 (US$ MN)
5.3 Agriculture
DATA TABLE Agriculture Market Forecast to 2027 (US$ MN)

6 RNAi Technologies Market, By Type
6.1 Micro RNAi
DATA TABLE Micro RNAi Market Forecast to 2027 (US$ MN)
6.2 Small interfering RNAi
DATA TABLE Small interfering RNAi Market Forecast to 2027 (US$ MN)

7 RNAi Technologies Market, By Geography
7.1 North America
DATA TABLE North America Market Forecast by Countries to 2027 (US$ MN)
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
DATA TABLE Europe Market Forecast by Countries to 2027 (US$ MN)
7.2.1 Germany
7.2.2 U.K
7.2.3 Italy
7.2.4 France
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
DATA TABLE Asia Pacific Market Forecast by Countries to 2027 (US$ MN)
7.3.1 China
7.3.2 Japan
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Middle East
DATA TABLE Middle East Market Forecast by Countries to 2027 (US$ MN)
7.4.1 Saudi Arabia
7.4.2 UAE
7.4.3 Rest of Middle East
7.5 Latin America
DATA TABLE Latin America Market Forecast by Countries to 2027 (US$ MN)
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Rest of Latin America
7.6 Rest of the World (RoW)
DATA TABLE RoW Market Forecast by Countries to 2027 (US$ MN)
7.6.1 South Africa
7.6.2 Others

8 Key Player Activities
8.1 Acquisitions & Mergers
8.2 Agreements, Partnerships, Collaborations and Joint Ventures
8.3 Product Launch & Expansions
8.4 Other Activities

9 Leading Companies
9.1 Thermo Fisher Scientific, Inc.
9.2 Syngenta International Ag
9.3 Monsanto Co.
9.4 General Electric Co.
9.5 F. Hoffmann-La Roche Ag
9.6 Benitec Biopharma Ltd
9.7 Alnylam Pharmaceuticals
9.8 Ionis Pharmaceuticals
9.9 RXI Pharmaceuticals
9.10 Quark Pharmaceuticals Inc.
9.11 Filmtec Corporation
9.12 Rosetta Genomics Ltd.
9.13 SANOFI
9.14 Nitto Denko Corp.
9.15 Biogen Idec, Inc.
9.16 Ambion
9.17 Qiagen
9.18 Invitrogen

List of Tables
Table 1 Global RNAi Technologies Market, By Region Market Forecast (2015-2027) (US $MN)
Table 2 Global RNAi Technologies Market, By Therapeutics Market Forecast (2015-2027) (US $MN)
Table 3 Global RNAi Technologies Market, By Ocular disorders Market Forecast (2015-2027) (US $MN)
Table 4 Global RNAi Technologies Market, By Respiratory disorders Market Forecast (2015-2027) (US $MN)
Table 5 Global RNAi Technologies Market, By Cardiology Market Forecast (2015-2027) (US $MN)
Table 6 Global RNAi Technologies Market, By Neurology Market Forecast (2015-2027) (US $MN)
Table 7 Global RNAi Technologies Market, By Liver diseases Market Forecast (2015-2027) (US $MN)
Table 8 Global RNAi Technologies Market, By Oncology Market Forecast (2015-2027) (US $MN)
Table 9 Global RNAi Technologies Market, By Metabolic disorders Market Forecast (2015-2027) (US $MN)
Table 10 Global RNAi Technologies Market, By Ophthalmology Market Forecast (2015-2027) (US $MN)
Table 11 Global RNAi Technologies Market, By Heart ailment Market Forecast (2015-2027) (US $MN)
Table 12 Global RNAi Technologies Market, By Autoimmune hepatitis Market Forecast (2015-2027) (US $MN)
Table 13 Global RNAi Technologies Market, By Application Market Forecast (2015-2027) (US $MN)
Table 14 Global RNAi Technologies Market, By Drug discovery Market Forecast (2015-2027) (US $MN)
Table 15 Global RNAi Technologies Market, By Medical research Market Forecast (2015-2027) (US $MN)
Table 16 Global RNAi Technologies Market, By Functional genomics Market Forecast (2015-2027) (US $MN)
Table 17 Global RNAi Technologies Market, By Specifically metabolism Market Forecast (2015-2027) (US $MN)
Table 18 Global RNAi Technologies Market, By Agriculture Market Forecast (2015-2027) (US $MN)
Table 19 Global RNAi Technologies Market, By Type Market Forecast (2015-2027) (US $MN)
Table 20 Global RNAi Technologies Market, By Micro RNAi Market Forecast (2015-2027) (US $MN)
Table 21 Global RNAi Technologies Market, By Small interfering RNAi Market Forecast (2015-2027) (US $MN)
Table 22 North America RNAi Technologies Market, By Region Market Forecast (2015-2027) (US $MN)
Table 23 North America RNAi Technologies Market, By Therapeutics Market Forecast (2015-2027) (US $MN)
Table 24 North America RNAi Technologies Market, By Ocular disorders Market Forecast (2015-2027) (US $MN)
Table 25 North America RNAi Technologies Market, By Respiratory disorders Market Forecast (2015-2027) (US $MN)
Table 26 North America RNAi Technologies Market, By Cardiology Market Forecast (2015-2027) (US $MN)
Table 27 North America RNAi Technologies Market, By Neurology Market Forecast (2015-2027) (US $MN)
Table 28 North America RNAi Technologies Market, By Liver diseases Market Forecast (2015-2027) (US $MN)
Table 29 North America RNAi Technologies Market, By Oncology Market Forecast (2015-2027) (US $MN)
Table 30 North America RNAi Technologies Market, By Metabolic disorders Market Forecast (2015-2027) (US $MN)
Table 31 North America RNAi Technologies Market, By Ophthalmology Market Forecast (2015-2027) (US $MN)
Table 32 North America RNAi Technologies Market, By Heart ailment Market Forecast (2015-2027) (US $MN)
Table 33 North America RNAi Technologies Market, By Autoimmune hepatitis Market Forecast (2015-2027) (US $MN)
Table 34 North America RNAi Technologies Market, By Application Market Forecast (2015-2027) (US $MN)
Table 35 North America RNAi Technologies Market, By Drug discovery Market Forecast (2015-2027) (US $MN)
Table 36 North America RNAi Technologies Market, By Medical research Market Forecast (2015-2027) (US $MN)
Table 37 North America RNAi Technologies Market, By Functional genomics Market Forecast (2015-2027) (US $MN)
Table 38 North America RNAi Technologies Market, By Specifically metabolism Market Forecast (2015-2027) (US $MN)
Table 39 North America RNAi Technologies Market, By Agriculture Market Forecast (2015-2027) (US $MN)
Table 40 North America RNAi Technologies Market, By Type Market Forecast (2015-2027) (US $MN)
Table 41 North America RNAi Technologies Market, By Micro RNAi Market Forecast (2015-2027) (US $MN)
Table 42 North America RNAi Technologies Market, By Small interfering RNAi Market Forecast (2015-2027) (US $MN)
Table 43 Europe RNAi Technologies Market, By Region Market Forecast (2015-2027) (US $MN)
Table 44 Europe RNAi Technologies Market, By Therapeutics Market Forecast (2015-2027) (US $MN)
Table 45 Europe RNAi Technologies Market, By Ocular disorders Market Forecast (2015-2027) (US $MN)
Table 46 Europe RNAi Technologies Market, By Respiratory disorders Market Forecast (2015-2027) (US $MN)
Table 47 Europe RNAi Technologies Market, By Cardiology Market Forecast (2015-2027) (US $MN)
Table 48 Europe RNAi Technologies Market, By Neurology Market Forecast (2015-2027) (US $MN)
Table 49 Europe RNAi Technologies Market, By Liver diseases Market Forecast (2015-2027) (US $MN)
Table 50 Europe RNAi Technologies Market, By Oncology Market Forecast (2015-2027) (US $MN)
Table 51 Europe RNAi Technologies Market, By Metabolic disorders Market Forecast (2015-2027) (US $MN)
Table 52 Europe RNAi Technologies Market, By Ophthalmology Market Forecast (2015-2027) (US $MN)
Table 53 Europe RNAi Technologies Market, By Heart ailment Market Forecast (2015-2027) (US $MN)
Table 54 Europe RNAi Technologies Market, By Autoimmune hepatitis Market Forecast (2015-2027) (US $MN)
Table 55 Europe RNAi Technologies Market, By Application Market Forecast (2015-2027) (US $MN)
Table 56 Europe RNAi Technologies Market, By Drug discovery Market Forecast (2015-2027) (US $MN)
Table 57 Europe RNAi Technologies Market, By Medical research Market Forecast (2015-2027) (US $MN)
Table 58 Europe RNAi Technologies Market, By Functional genomics Market Forecast (2015-2027) (US $MN)
Table 59 Europe RNAi Technologies Market, By Specifically metabolism Market Forecast (2015-2027) (US $MN)
Table 60 Europe RNAi Technologies Market, By Agriculture Market Forecast (2015-2027) (US $MN)
Table 61 Europe RNAi Technologies Market, By Type Market Forecast (2015-2027) (US $MN)
Table 62 Europe RNAi Technologies Market, By Micro RNAi Market Forecast (2015-2027) (US $MN)
Table 63 Europe RNAi Technologies Market, By Small interfering RNAi Market Forecast (2015-2027) (US $MN)
Table 64 Asia Pacific RNAi Technologies Market, By Region Market Forecast (2015-2027) (US $MN)
Table 65 Asia Pacific RNAi Technologies Market, By Therapeutics Market Forecast (2015-2027) (US $MN)
Table 66 Asia Pacific RNAi Technologies Market, By Ocular disorders Market Forecast (2015-2027) (US $MN)
Table 67 Asia Pacific RNAi Technologies Market, By Respiratory disorders Market Forecast (2015-2027) (US $MN)
Table 68 Asia Pacific RNAi Technologies Market, By Cardiology Market Forecast (2015-2027) (US $MN)
Table 69 Asia Pacific RNAi Technologies Market, By Neurology Market Forecast (2015-2027) (US $MN)
Table 70 Asia Pacific RNAi Technologies Market, By Liver diseases Market Forecast (2015-2027) (US $MN)
Table 71 Asia Pacific RNAi Technologies Market, By Oncology Market Forecast (2015-2027) (US $MN)
Table 72 Asia Pacific RNAi Technologies Market, By Metabolic disorders Market Forecast (2015-2027) (US $MN)
Table 73 Asia Pacific RNAi Technologies Market, By Ophthalmology Market Forecast (2015-2027) (US $MN)
Table 74 Asia Pacific RNAi Technologies Market, By Heart ailment Market Forecast (2015-2027) (US $MN)
Table 75 Asia Pacific RNAi Technologies Market, By Autoimmune hepatitis Market Forecast (2015-2027) (US $MN)
Table 76 Asia Pacific RNAi Technologies Market, By Application Market Forecast (2015-2027) (US $MN)
Table 77 Asia Pacific RNAi Technologies Market, By Drug discovery Market Forecast (2015-2027) (US $MN)
Table 78 Asia Pacific RNAi Technologies Market, By Medical research Market Forecast (2015-2027) (US $MN)
Table 79 Asia Pacific RNAi Technologies Market, By Functional genomics Market Forecast (2015-2027) (US $MN)
Table 80 Asia Pacific RNAi Technologies Market, By Specifically metabolism Market Forecast (2015-2027) (US $MN)
Table 81 Asia Pacific RNAi Technologies Market, By Agriculture Market Forecast (2015-2027) (US $MN)
Table 82 Asia Pacific RNAi Technologies Market, By Type Market Forecast (2015-2027) (US $MN)
Table 83 Asia Pacific RNAi Technologies Market, By Micro RNAi Market Forecast (2015-2027) (US $MN)
Table 84 Asia Pacific RNAi Technologies Market, By Small interfering RNAi Market Forecast (2015-2027) (US $MN)
Table 85 Middle East RNAi Technologies Market, By Region Market Forecast (2015-2027) (US $MN)
Table 86 Middle East RNAi Technologies Market, By Therapeutics Market Forecast (2015-2027) (US $MN)
Table 87 Middle East RNAi Technologies Market, By Ocular disorders Market Forecast (2015-2027) (US $MN)
Table 88 Middle East RNAi Technologies Market, By Respiratory disorders Market Forecast (2015-2027) (US $MN)
Table 89 Middle East RNAi Technologies Market, By Cardiology Market Forecast (2015-2027) (US $MN)
Table 90 Middle East RNAi Technologies Market, By Neurology Market Forecast (2015-2027) (US $MN)
Table 91 Middle East RNAi Technologies Market, By Liver diseases Market Forecast (2015-2027) (US $MN)
Table 92 Middle East RNAi Technologies Market, By Oncology Market Forecast (2015-2027) (US $MN)
Table 93 Middle East RNAi Technologies Market, By Metabolic disorders Market Forecast (2015-2027) (US $MN)
Table 94 Middle East RNAi Technologies Market, By Ophthalmology Market Forecast (2015-2027) (US $MN)
Table 95 Middle East RNAi Technologies Market, By Heart ailment Market Forecast (2015-2027) (US $MN)
Table 96 Middle East RNAi Technologies Market, By Autoimmune hepatitis Market Forecast (2015-2027) (US $MN)
Table 97 Middle East RNAi Technologies Market, By Application Market Forecast (2015-2027) (US $MN)
Table 98 Middle East RNAi Technologies Market, By Drug discovery Market Forecast (2015-2027) (US $MN)
Table 99 Middle East RNAi Technologies Market, By Medical research Market Forecast (2015-2027) (US $MN)
Table 100 Middle East RNAi Technologies Market, By Functional genomics Market Forecast (2015-2027) (US $MN)
Table 101 Middle East RNAi Technologies Market, By Specifically metabolism Market Forecast (2015-2027) (US $MN)
Table 102 Middle East RNAi Technologies Market, By Agriculture Market Forecast (2015-2027) (US $MN)
Table 103 Middle East RNAi Technologies Market, By Type Market Forecast (2015-2027) (US $MN)
Table 104 Middle East RNAi Technologies Market, By Micro RNAi Market Forecast (2015-2027) (US $MN)
Table 105 Middle East RNAi Technologies Market, By Small interfering RNAi Market Forecast (2015-2027) (US $MN)
Table 106 Latin America RNAi Technologies Market, By Region Market Forecast (2015-2027) (US $MN)
Table 107 Latin America RNAi Technologies Market, By Therapeutics Market Forecast (2015-2027) (US $MN)
Table 108 Latin America RNAi Technologies Market, By Ocular disorders Market Forecast (2015-2027) (US $MN)
Table 109 Latin America RNAi Technologies Market, By Respiratory disorders Market Forecast (2015-2027) (US $MN)
Table 110 Latin America RNAi Technologies Market, By Cardiology Market Forecast (2015-2027) (US $MN)
Table 111 Latin America RNAi Technologies Market, By Neurology Market Forecast (2015-2027) (US $MN)
Table 112 Latin America RNAi Technologies Market, By Liver diseases Market Forecast (2015-2027) (US $MN)
Table 113 Latin America RNAi Technologies Market, By Oncology Market Forecast (2015-2027) (US $MN)
Table 114 Latin America RNAi Technologies Market, By Metabolic disorders Market Forecast (2015-2027) (US $MN)
Table 115 Latin America RNAi Technologies Market, By Ophthalmology Market Forecast (2015-2027) (US $MN)
Table 116 Latin America RNAi Technologies Market, By Heart ailment Market Forecast (2015-2027) (US $MN)
Table 117 Latin America RNAi Technologies Market, By Autoimmune hepatitis Market Forecast (2015-2027) (US $MN)
Table 118 Latin America RNAi Technologies Market, By Application Market Forecast (2015-2027) (US $MN)
Table 119 Latin America RNAi Technologies Market, By Drug discovery Market Forecast (2015-2027) (US $MN)
Table 120 Latin America RNAi Technologies Market, By Medical research Market Forecast (2015-2027) (US $MN)
Table 121 Latin America RNAi Technologies Market, By Functional genomics Market Forecast (2015-2027) (US $MN)
Table 122 Latin America RNAi Technologies Market, By Specifically metabolism Market Forecast (2015-2027) (US $MN)
Table 123 Latin America RNAi Technologies Market, By Agriculture Market Forecast (2015-2027) (US $MN)
Table 124 Latin America RNAi Technologies Market, By Type Market Forecast (2015-2027) (US $MN)
Table 125 Latin America RNAi Technologies Market, By Micro RNAi Market Forecast (2015-2027) (US $MN)
Table 126 Latin America RNAi Technologies Market, By Small interfering RNAi Market Forecast (2015-2027) (US $MN)
Table 127 RoW RNAi Technologies Market, By Region Market Forecast (2015-2027) (US $MN)
Table 128 RoW RNAi Technologies Market, By Therapeutics Market Forecast (2015-2027) (US $MN)
Table 129 RoW RNAi Technologies Market, By Ocular disorders Market Forecast (2015-2027) (US $MN)
Table 130 RoW RNAi Technologies Market, By Respiratory disorders Market Forecast (2015-2027) (US $MN)
Table 131 RoW RNAi Technologies Market, By Cardiology Market Forecast (2015-2027) (US $MN)
Table 132 RoW RNAi Technologies Market, By Neurology Market Forecast (2015-2027) (US $MN)
Table 133 RoW RNAi Technologies Market, By Liver diseases Market Forecast (2015-2027) (US $MN)
Table 134 RoW RNAi Technologies Market, By Oncology Market Forecast (2015-2027) (US $MN)
Table 135 RoW RNAi Technologies Market, By Metabolic disorders Market Forecast (2015-2027) (US $MN)
Table 136 RoW RNAi Technologies Market, By Ophthalmology Market Forecast (2015-2027) (US $MN)
Table 137 RoW RNAi Technologies Market, By Heart ailment Market Forecast (2015-2027) (US $MN)
Table 138 RoW RNAi Technologies Market, By Autoimmune hepatitis Market Forecast (2015-2027) (US $MN)
Table 139 RoW RNAi Technologies Market, By Application Market Forecast (2015-2027) (US $MN)
Table 140 RoW RNAi Technologies Market, By Drug discovery Market Forecast (2015-2027) (US $MN)
Table 141 RoW RNAi Technologies Market, By Medical research Market Forecast (2015-2027) (US $MN)
Table 142 RoW RNAi Technologies Market, By Functional genomics Market Forecast (2015-2027) (US $MN)
Table 143 RoW RNAi Technologies Market, By Specifically metabolism Market Forecast (2015-2027) (US $MN)
Table 144 RoW RNAi Technologies Market, By Agriculture Market Forecast (2015-2027) (US $MN)
Table 145 RoW RNAi Technologies Market, By Type Market Forecast (2015-2027) (US $MN)
Table 146 RoW RNAi Technologies Market, By Micro RNAi Market Forecast (2015-2027) (US $MN)
Table 147 RoW RNAi Technologies Market, By Small interfering RNAi Market Forecast (2015-2027) (US $MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Thermo Fisher Scientific, Inc.
  • Syngenta International Ag
  • Monsanto Co.
  • General Electric Co.
  • F. Hoffmann-La Roche Ag
  • Benitec Biopharma Ltd
  • Alnylam Pharmaceuticals
  • Ionis Pharmaceuticals
  • RXI Pharmaceuticals
  • Quark Pharmaceuticals Inc.
  • Filmtec Corporation
  • Rosetta Genomics Ltd.
  • SANOFI
  • Nitto Denko Corp.
  • Biogen Idec, Inc.
  • Ambion
  • Qiagen
  • Invitrogen
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll